Gilles Pagès

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 7

Top Venues

Cancers

Journal of experimental & clinical cancer research : CR

Autophagy

International journal of molecular sciences

INSERM Délégation régionale Provence Alpes Cote d'Azur et Corse

This page only lists publications with an associated author ORCID identifier.

Affiliation History

INSERM Délégation régionale Provence Alpes Cote d'Azur et Corse Jan 01 2013

France

DR1 :: Alpes Maritimes

Publications

Christopher Montemagno, Jérôme Durivault, Cécile Gastaldi, Maeva Dufies, Valérie Vial, Xingkang He, Damien Ambrosetti, Anna Kamenskaya, Sylvie Negrier, Jean-Christophe Bernhard, Delphine Borchiellini, Yihai Cao, Gilles Pagès
A group of novel VEGF splice variants as alternative therapeutic targets in renal cell carcinoma. Molecular oncology (2023)
Sandy Giuliano, Christopher Montemagno, Marie-Angela Domdom, Manon Teisseire, Patrick Brest, Daniel J Klionsky, Paul Hofman, Gilles Pagès, Baharia Mograbi
Should evidence of an autolysosomal de-acidification defect in Alzheimer and Parkinson diseases call for caution in prescribing chronic PPI and DMARD? Autophagy (2023)
Doria Filipponi, Marina Pagnuzzi-Boncompagni, Gilles Pagès
Inhibiting ALK2/ALK3 Signaling to Differentiate and Chemo-Sensitize Medulloblastoma. Cancers 14 (9) (2022)
Marina Pagnuzzi-Boncompagni, Vincent Picco, Valérie Vial, Victor Planas-Bielsa, Ashaina Vandenberghe, Thomas Daubon, Marie-Alix Derieppe, Christopher Montemagno, Jérôme Durivault, Renaud Grépin, Sonia Martial, Jérôme Doyen, Julie Gavard, Gilles Pagès
Antiangiogenic Compound Axitinib Demonstrates Low Toxicity and Antitumoral Effects against Medulloblastoma. Cancers 14 (1) (2021)
Aurore Dumond, Etienne Brachet, Jérôme Durivault, Valérie Vial, Anna K Puszko, Yves Lepelletier, Christopher Montemagno, Marina Pagnuzzi-Boncompagni, Olivier Hermine, Christiane Garbay, Nathalie Lagarde, Matthieu Montes, Luc Demange, Renaud Grépin, Gilles Pagès
Neuropilin 1 and Neuropilin 2 gene invalidation or pharmacological inhibition reveals their relevance for the treatment of metastatic renal cell carcinoma. Journal of experimental & clinical cancer research : CR 40 (1) (2021)
Aurore Dumond, Christopher Montemagno, Valérie Vial, Renaud Grépin, Gilles Pagès
Anti-Vascular Endothelial Growth Factor C Antibodies Efficiently Inhibit the Growth of Experimental Clear Cell Renal Cell Carcinomas. Cells 10 (5) (2021)
Christopher Montemagno, Shamir Cassim, Jacques Pouysségur, Alexis Broisat, Gilles Pagès
From Malignant Progression to Therapeutic Targeting: Current Insights of Mesothelin in Pancreatic Ductal Adenocarcinoma. International journal of molecular sciences 21 (11) (2020)

Gilles Pagès.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Gilles Pagès